Awaiting development: Guidance and quality standards
Showing 1 to 2 of 2
| Title | Type |
|---|---|
| Lisocabtagene maraleucel for treating relapsed or refractory low-grade B-cell follicular lymphoma after 1 or more treatments [ID6564] | Technology appraisal guidance |
| Lisocabtagene maraleucel for treating relapsed or refractory mantle cell lymphoma [ID6695] | Technology appraisal guidance |